Simultaneous analysis of catechol-O-methyl transferase activity, S-adenosylhomocysteine and adenosine

Biomedical Chromatography

Volumn 24, Issue 3, 2010, Pages 294-300

  Reenilä, Ilkka ^a,b   Rauhala, Pekka ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Catechol O methyltransferase; Entacapone; HPLC; S adenosylhomocysteine; S adenosyl L methionine

Indexed keywords

ALKYLATION; AMINO ACIDS; METHYLATION; PHENOLS;

CATECHOL-O-METHYLTRANSFERASE; ENTACAPONE; HPLC; HPLC METHOD; L-METHIONINE; METHYLTRANSFERASES; S-ADENOSYL-L-METHIONINE; S-ADENOSYLHOMOCYSTEINE; SIMULTANEOUS ANALYSIS; UV DETECTION;

TISSUE;

ADENOSINE; BENZOIC ACID DERIVATIVE; CATECHOL METHYLTRANSFERASE; ENTACAPONE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; VANILLIC ACID;

AMINO ACID ANALYSIS; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY HOMOGENATE; METHYLATION; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; RAT; ULTRAVIOLET RADIATION;

RATTUS;

EID: 76149110109     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1288     Document Type: Article

References (24)

1. Cheng H, Gomes-Trolin C, Aquilonius SM, Steinberg A, Lofberg C, Ekblom J and Oreland L. Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease. Experimental Neurology 1997; 145: 580-585.
2. Da Prada M, Borgulya J, Napolitano A and Zú́rcher G. Improved therapy of Parkinson's disease with tolcapone, a central and peripheral COMT inhibitor with an S-adenosyl-L-methionine-sparing effect. Clinical Neuropharmacology 1994; 17: S26-S37.
3. Delabar U, Kloor D, Luippold G and Muhlbauer B. Simultaneous determination of adenosine, S-adenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 1999; 724: 231-238.
4. Delaney SM and Geiger JD. Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation. Journal of Neuroscience Methods 1996; 64: 151-156.
5. Fu W, Dudman NPB, Pery MA, Young K and Wang XL. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine. Biochemical and Biophysical Research Communications 2000; 271: 47-53.
6. Liu XX, Wilson K and Charlton CG. Effects of L-DOPA treatment on methylation in mouse brain: implications for the side effects of L-DOPA. Life Science 2000; 66: 2277-2288.
7. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I and Taskinen J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995; 34: 4202-4210.
8. Luippold G, Delabar U, Kloor D and Mú́hlbauer B. Simultaneous determination of adenosine, S-adenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1999; 724: 231-238.
9. Männistö PT and Kaakkola S. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacological Reviews 1999; 51: 593-628.
10. Mattson MP and Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends in Neuroscience 2003; 26: 137-146.
11. Miller JW, Shukitt-Hale B, Villalobos-Molina R, Nadeau MR, Selhub J, Joshep JA. Effect of L-DOPA and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats. Clinical Neurophramacology 1997; 20: 55-66.
12. Miller JW, Selhub J, Nadeau MR, Thomas CA, Feldman RG and Wolf PA. Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology 2003; 60: 1125-1129.
13. Müller T, Woitalla D, Hauptmann B, Fowler B and Kuhn W. Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease. Neuroscience Letters 2001; 308: 54-56.
14. Nissinen E, Lindén IB, Schultz E, Kaakkola S, Männistö PT and Pohto P. Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat. European Journal of Pharmacology 1988; 153: 263-269.
15. Nissinen E, Nissinen H, Larjonmaa H, Vaananen A, Helkamaa T, Reenila I and Rauhala P. The COMT inhibitor, entacapone, reduces levodopainduced elevations in plasma homocysteine in healthy adult rats. Journal of Neural Transmitters 2004; 112: 1213-1221.
16. Pennings JM and Van Kempen GMJ. Assay of catechol-O-methyltransferase by determination of the m- and p-O-methylated products using high-performance liquid chromatography. Analytical Biochemistry 1979; 98: 452-454.
17. Pihlavisto P and Reenila I. Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2002; 781: 359-72.
18. Poewe W. The role of COMT inhibition in the treatment of Parkinson's disease. Neurology 2004; 62: S31-38.
19. Reenilä IT, Tuomainen PT and Männistö PT. Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 1995; 663: 137-142.
20. Ribeiro JA, Sebastiao AM and de Mendonca A. Adenosine receptors in the nervous system: pathophysiological implications. Progress in Neurobiology 2003; 68: 377-437.
21. Riksen NP, Rongen GA, Blom HJ, Russel FGM, Boers GHJ and Smits P. Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia. Cardiovascular Research 2003; 59: 271-276.
22. 6 defi ciency on these concentrations in rat liver. Biochemical and Biophysical Research Communications 1994; 205: 1748-1754.
23. Wang W, Kramer PM, Yang S, Pereira MA and Tao L. Reversed-phase high-performance liquid chromatography procedure for the simultaneous determination of S-adenosy-L-methionine and S-adenosyl- L-homocysteine in mouse liver and the eff ect of methionine on their concentrations. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2001; 762: 59-65.
24. Zhu BT. On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis. Histology and Histopathology 2002; 17: 1283-1291.